150 related articles for article (PubMed ID: 27492634)
1. Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.
Du Y; Ter-Minassian M; Brais L; Brooks N; Waldron A; Chan JA; Lin X; Kraft P; Christiani DC; Kulke MH
Endocr Relat Cancer; 2016 Aug; 23(8):587-94. PubMed ID: 27492634
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).
Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
[TBL] [Abstract][Full Text] [Related]
3. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
Cabezas Agrícola JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
[TBL] [Abstract][Full Text] [Related]
4. Associations between Single Nucleotide Polymorphisms in the Mitochondrial DNA D-Loop Region and Outcome of Gastroenteropancreatic Neuroendocrine Neoplasm.
Er LM; Li Y; Er L; Wu M; Zheng XL; Guo ZJ; Yuan HF
Ann Clin Lab Sci; 2018 May; 48(3):333-337. PubMed ID: 29970437
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations with sporadic neuroendocrine tumor risk.
Ter-Minassian M; Wang Z; Asomaning K; Wu MC; Liu CY; Paulus JK; Liu G; Bradbury PA; Zhai R; Su L; Frauenhoffer CS; Hooshmand SM; De Vivo I; Lin X; Christiani DC; Kulke MH
Carcinogenesis; 2011 Aug; 32(8):1216-22. PubMed ID: 21606320
[TBL] [Abstract][Full Text] [Related]
6. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.
Campa D; Capurso G; Pastore M; Talar-Wojnarowska R; Milanetto AC; Landoni L; Maiello E; Lawlor RT; Malecka-Panas E; Funel N; Gazouli M; De Bonis A; Klüter H; Rinzivillo M; Delle Fave G; Hackert T; Landi S; Bugert P; Bambi F; Archibugi L; Scarpa A; Katzke V; Dervenis C; Liço V; Furlanello S; Strobel O; Tavano F; Basso D; Kaaks R; Pasquali C; Gentiluomo M; Rizzato C; Canzian F
Sci Rep; 2016 Dec; 6():39565. PubMed ID: 28008994
[TBL] [Abstract][Full Text] [Related]
7. Germline genetic variability in pancreatic cancer risk and prognosis.
Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
[TBL] [Abstract][Full Text] [Related]
8. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
[TBL] [Abstract][Full Text] [Related]
10. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
[TBL] [Abstract][Full Text] [Related]
11. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
[TBL] [Abstract][Full Text] [Related]
12. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
13. Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.
Kidd M; Modlin IM; Drozdov I
BMC Genomics; 2014 Jul; 15(1):595. PubMed ID: 25023465
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
[TBL] [Abstract][Full Text] [Related]
15. Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.
Shan YS; Chen LT; Wu JS; Chang YF; Lee CT; Wu CH; Chiang NJ; Huang HE; Yen CJ; Chao YJ; Tsai HJ; Chen CY; Kang JW; Kuo CF; Tsai CR; Weng YL; Yang HC; Liu HC; Chang JS
J Biomed Sci; 2020 May; 27(1):69. PubMed ID: 32456644
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
Tang H; Wei P; Chang P; Li Y; Yan D; Liu C; Hassan M; Li D
Int J Cancer; 2017 Aug; 141(4):678-686. PubMed ID: 28470677
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors.
Fazio N; Martini JF; Croitoru AE; Schenker M; Li S; Rosbrook B; Fernandez K; Tomasek J; Thiis-Evensen E; Kulke M; Raymond E
Future Oncol; 2019 Jun; 15(17):1997-2007. PubMed ID: 31084373
[No Abstract] [Full Text] [Related]
19. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
